Impact of Tumor-Infiltrating Lymphocyte Density on Outcomes in Patients With TNBC Treated With Anthracycline-Free Neoadjuvant Chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tumor-infiltrating lymphocytes refine outcomes in triple-negative breast cancer treated with anthracycline-free neoadjuvant chemotherapy
Clin. Cancer Res 2024 Mar 11;[EPub Ahead of Print], M Martín, R Yoder, R Salgado, M Del Monte-Millán, EL Alvarez, I Echavarría, JM Staley, AP O'Dea, LE Nye, SR Stecklein, C Bueno Muiño, Y Jerez-Gilarranz, M Cebollero, O Bueno, JÁ Garcia-Saenz, F Moreno, U Bohn, H Gomez, T Massarrah, QJ Khan, AK Godwin, S López-Tarruella, P SharmaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.